These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 371818)

  • 1. Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response.
    Leclerc C; Juy D; Chedid L
    Cell Immunol; 1979 Feb; 42(2):336-43. PubMed ID: 371818
    [No Abstract]   [Full Text] [Related]  

  • 2. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Löwy I; Leclerc C; Chedid L
    Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
    Chedid L; Lederer E
    Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
    Jolivet M; Sache E; Audibert F
    Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
    Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
    Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
    Chedid L; Audibert F; Johnson AG
    Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems.
    Reichert CM; Carelli C; Jolivet M; Audibert F; Lefrancier P; Chedid L
    Mol Immunol; 1980 Mar; 17(3):357-63. PubMed ID: 7442679
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
    Damais C; Parant M; Chedid L; Lefrancier P; Choay J
    Cell Immunol; 1978 Jan; 35(1):173-9. PubMed ID: 563773
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
    Dzheksenbaev OSh
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of concanavalin A in vivo in suppressing the antibody response in mice.
    Egan HS; Reeder WJ; Ekstedt RD
    J Immunol; 1974 Jan; 112(1):63-9. PubMed ID: 4590828
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
    Chedid L; Carelli C; Audibert F
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular requirements for the primary in vitro antibody response to DNP-ficoll.
    Mosier DE; Johnson BM; Paul WE; McMaster PR
    J Exp Med; 1974 May; 139(5):1354-60. PubMed ID: 4596514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells.
    Möller G; Sjöberg O
    Cell Immunol; 1970 May; 1(1):110-21. PubMed ID: 4943425
    [No Abstract]   [Full Text] [Related]  

  • 20. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
    Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.